남성 만성 조현병 환자에서 혈중 테스토스테론 농도와 인지 기능의 상관관계
The Association between Serum Testosterone Level and Cognitive Function in Men with Chronic Schizophrenia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives:The purpose of this study was to investigate the relationships between sexual hormone level and cognition in male patients with schizophrenia. Methods:Total 80 male patients with schizophrenia were involved in this study. Among them, 61 patients were classified into normal cognition group(NCG) and 19 patients for lower cognition group(LCG), according to the Korean version of Consortium to Establish a Registry for Alzheimer’s Disease(CERAD-K) and Korean-Color Word Stroop Test. LCG was identified who were included at the below 5 percentile in at least one domain of the cognitive test. All the participants completed Positive and Negative Syndrome Scale(PANSS), Simpson Angus rating Scales(SAS) and Hamilton rating scale for Depression(HAM-D). Sexual hormone levels of prolactin, total testosterone, free-testosterone and estradiol were also checked by blood hormonal assays. Results:The patients with higher total testosterone level on construction domain were more likely to be included in LCG than NCG. Statistically significant correlations were still observed after adjustment of the several covariants. Total testosterone, free testosterone and estradiol levels have statistically significant positive correlations between each other, but there were negative correlations between prolactin and other hormone levels in 80 male patients with schizophrenia. Conclusion:These results suggest that sexual hormone may modulate the cognitive deficits in patients with chronic schizophrenia. Sexual hormone levels would be considered as predictive factors about cognitive function of patients with chronic schizophrenia. Furthermore, longitudinal and large-scale control studies would be needed to confirm these results.
Abstract
Objectives:The purpose of this study was to investigate the relationships between sexual hormone level and cognition in male patients with schizophrenia. Methods:Total 80 male patients with schizophrenia were involved in this study. Among them, 61 patients were classified into normal cognition group(NCG) and 19 patients for lower cognition group(LCG), according to the Korean version of Consortium to Establish a Registry for Alzheimer’s Disease(CERAD-K) and Korean-Color Word Stroop Test. LCG was identified who were included at the below 5 percentile in at least one domain of the cognitive test. All the participants completed Positive and Negative Syndrome Scale(PANSS), Simpson Angus rating Scales(SAS) and Hamilton rating scale for Depression(HAM-D). Sexual hormone levels of prolactin, total testosterone, free-testosterone and estradiol were also checked by blood hormonal assays. Results:The patients with higher total testosterone level on construction domain were more likely to be included in LCG than NCG. Statistically significant correlations were still observed after adjustment of the several covariants. Total testosterone, free testosterone and estradiol levels have statistically significant positive correlations between each other, but there were negative correlations between prolactin and other hormone levels in 80 male patients with schizophrenia. Conclusion:These results suggest that sexual hormone may modulate the cognitive deficits in patients with chronic schizophrenia. Sexual hormone levels would be considered as predictive factors about cognitive function of patients with chronic schizophrenia. Furthermore, longitudinal and large-scale control studies would be needed to confirm these results.
참고문헌 (45)
- McGrath J, "Schizophrenia: a concise overview of incidence, prevalence, and mortality", Epidemiol Rev, 30, pp.67~76 (2008)
- Abel KM, "Sex differences in schizophrenia", Int Rev Psychiatry, 22, pp.417~428 (2010)
- Green MF, "Cognition in schizophrenia: Past, present, and future", Schizophr Res Cogn, 1, pp.e1~e9 (2014)
- Maat A, "Social cognition and quality of life in schizophrenia", Schizophr Res, 137, pp.212~218 (2012)
- Harvey PD, "Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia", Schizophr Res, 66, pp.101~113 (2004)
- de Bartolomeis A, "Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses", Psychiatry Res, 210, pp.387~395 (2013)
- Rathod S, "Cognitive Behavioral Therapy for Schizophrenia", Psychiatr Clin North Am, 33, pp.527~536 (2010)
- Garrido G, "Computer-assisted cognitive remediation therapy: Cognition, self-esteem and quality of life in schizophrenia", Schizophr Res, 150, pp.563~569 (2013)
- Brann DW, "Neurotrophic and neuroprotective actions of estrogen : Basic mechanisms and clinical implications", Steroids, 72, pp.381~405 (2007)
- Pike CJ, "Protective actions of sex steroid hormones in Alzheimer’s disease", Front Neuroendocrinol, 30, pp.239~258 (2009)
- Sherwin BB., "Steroid hormones and cognitive functioning in aging men : a mini-review", J Mol Neurosci, 20, pp.385~393 (2003)
- Matousek RH, "Sex steroid hormones and cognitive functioning in healthy, older men", Horm Behav, 57, pp.352~359 (2010)
- Cherrier MM, "Testosterone supplementation improves spatial and verbal memory in healthy older men", Neurology, 57, pp.80~88 (2001)
- Cherrier MM, "Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men", Psychoneuroendocrinology, 32, pp.72~79 (2007)
- Holland J, "Testosterone levels and cognition in elderly men : A review", Maturitas, 69, pp.322~337 (2011)
- Akhondzadeh S, "Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia", Schizophr Res, 84, pp.405~410 (2006)
- Ko YH, "Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia", Psychoneuroendocrinology, 32, pp.385~391 (2007)
- Moore L, "Serum testosterone levels are related to cognitive function in men with schizophrenia", Psychoneuroendocrinology, 38, pp.1717~1728 (2013)
- 이중서, "한국판 양성 및 음성증후군 척도(Positive and Negative Syndrome Scale)의 신뢰도와 타당도", 신경정신의학, 40(6), pp.1090~1105 (2001), 대한신경정신의학회
- Simpson GM, "A rating scale for extrapyramidal side effects", Acta Psychiatr Scand Suppl, 212, pp.11~19 (1970)
- Lee JH, "Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet(CERAD-K): clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.P47~P53 (2002)
- Shin MS, "Stroop Color and Word Test, a Manual for Clinical and Experimental Uses", pp.91~ (2007), Hakjisa
- Lezak MD, "Neuropsychological assessement", pp.1056~ (1995), Oxford University Press
- Nuechterlein KH, "The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity", Am J Psychiatry, 165, pp.203~213 (2008)
- 이중서, "한국판 Hamilton 우울증 평가 척도의 신뢰도, 타당도 연구", 신경정신의학, 44(4), pp.456~465 (2005), 대한신경정신의학회
- Gardner DM, "International consensus study of antipsychotic dosing", Am J Psychiatry, 167, pp.686~693 (2010)
- Petersen RC, "Mild cognitive impairment : clinical characterization and outcome", Arch Neurol, 56, pp.303~308 (1999)
- McKhann G, "Clinical diagnosis of Alzheimer’s disease Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
- Montalvo I, "Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis", PLoS One, 9, pp.e89428~ (2014)
- Torner L, "Hyperprolactinemia impairs object recognition without altering spatial learning in male rats", Behav Brain Res, 252, pp.32~39 (2013)
- Muller M, "Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level?", Neurology, 64, pp.866~871 (2005)
- Martin DM, "Endogenous testosterone levels, mental rotation performance, and constituent abilities in middle-to-older aged men", Horm Behav, 53, pp.431~441 (2008)
- Van Strien JW, "Higher free testosterone level is associated with faster visual processing and more flanker interference in older men", Psychoneuroendocrinology, 34, pp.546~554 (2009)
- Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute scientific statement: Executive Summary, 2005, pp.4, 198~203
- Lim S, "Increasing Prevalence of Metabolic Syndrome in Korea The Korean National Health and Nutrition Examination Survey for 1998-2007", Diabetes Care, 34, pp.1323~1328 (2011)
- Lee SJ, "Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications", Annu Rev Pharmacol Toxicol, 41, pp.569~591 (2001)
- Bicknell RJ, "Sex-steroid action on neurotransmission", Curr Opin Neurol, 11, pp.667~671 (1998)
- Behl C, "Sex hormones, neuroprotection and cognition", Prog Brain Res, 138, pp.135~142 (2002)
- Garcia-Segura LM, "Neuroprotection by estradiol", Prog Neurobiol, 63, pp.29~60 (2001)
- Halbreich U, "Elevated prolactin levels in patients with schizophrenia : mechanisms and related adverse effects", Psychoneuroendocrinology, 28(Suppl 1), pp.53~67 (2003)
- Gooren LJ, "Significance of oestrogens in male(patho)physiology", Ann Endocrinol, 64, pp.126~135 (2003)
- Vermeulen A, "Estradiol in elderly men", Aging Male, 5, pp.98~102 (2002)
- Dunn JF, "Transport of steroid hormones : binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma", J Clin Endocrinol Metab, 53, pp.58~68 (1981)
- Byerly M, "Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders : recent developments and current perspectives", J Clin Psychopharmacol, 27, pp.639~661 (2007)
- Besnard I, "Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance", Encephale, 40, pp.86~94 (2014)
